© Reuters. FILE PHOTO: Oxford University/AstraZeneca COVID-19 vaccine at Princess Royal Hospital in Haywards Heath

BRASILIA (Reuters) – Brazil’s health regulator Anvisa said late on Saturday it had approved the import of 2 million doses of the COVID-19 vaccine developed by AstraZeneca (NASDAQ:) and the University of Oxford, although the jab is not yet approved for use in the country.

Anvisa said it approved the importation request from federal government-affiliated biomedical center Fiocruz on Thursday.

Importing the doses prior to approval will enable vaccination to begin as soon as Anvisa okays its use, the regulator said. Brazil has yet to approve any vaccine.

Fiocruz will apply for emergency use of the vaccine by Wednesday, its president, Nísia Trindade, said last week.

Brazil has recorded the second-deadliest outbreak of COVID-19 after only the United States. South America’s largest country has the third highest tally of coronavirus cases, with the health ministry registering more than 7.7 million, after the United States and India.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *